中国特发性肺纤维化临床-影像-病理诊断规范

2018-02-20 中华医学会病理学分会胸部疾病学组 中华病理学杂志, 2018,47(2) : 81-86.

特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是特发性间质性肺炎(idiopathic interstitial pneumonias,IIP)中最重要的亚型,其病因和发病机制不清,目前无有效治疗方法,预后差。IPF的病理诊断一直是病理医师工作的难点。2011年美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科学会发表了"IPF诊治循证指南"(简称国际共识

中文标题:

中国特发性肺纤维化临床-影像-病理诊断规范

发布日期:

2018-02-20

简要介绍:

特发性肺纤维化(idiopathic pulmonary fibrosis,IPF)是特发性间质性肺炎(idiopathic interstitial pneumonias,IIP)中最重要的亚型,其病因和发病机制不清,目前无有效治疗方法,预后差。IPF的病理诊断一直是病理医师工作的难点。2011年美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科学会发表了"IPF诊治循证指南"(简称国际共识),再次强调IPF的明确诊断依赖于临床-影像-病理结合的诊断(clinico-radiologic-pathologic diagnosis, CRP诊断),即多学科讨论的重要性。国际共识对提高我国IPF的整体诊断水平起到了促进作用,但远不能适应中国的实情。一是我国病理医师普遍缺乏CRP诊断的经验,二是病理诊断缺少可操作的规范。2016年中华医学会呼吸分会间质病学组组织制定了"IPF诊断和治疗中国专家共识",主要从呼吸科医师的角度,讨论如何结合病理诊断和影像学表现进行IPF的诊断和治疗,并不完全适用于病理医师进行IPF的诊断。有鉴于此,为了提高IPF的诊断水平,本学组研究并制定了中国IPF的CRP诊断规范。

 

拓展指南:肺纤维化相关指南:

下载附件:

(因为版权问题,不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=973307, encodeId=2aec9e330753, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 13 18:29:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82273, encryptionId=7d71822e3e5, topicName=肺纤维化)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 06 11:40:11 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350631, encodeId=18aa350631b1, content=努力规范治疗,科学管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bj6C0FlaktgGwCTS7f0JsJHJrJZzjsIs01O5E893pPNfnxjbAtkhr5ocn6biau9PH1TE21jyr12GAA9zKBxUtpA/132, createdBy=c0d31628590, createdName=luolizhu, createdTime=Sat Oct 27 07:22:57 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291476, encodeId=b69b2914e6cc, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ec2274185, createdName=121afdd5m30暂无昵称, createdTime=Tue Feb 27 20:16:36 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291444, encodeId=0e51291444d1, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Feb 27 16:56:26 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2021-06-13 14775a26m11暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=973307, encodeId=2aec9e330753, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 13 18:29:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82273, encryptionId=7d71822e3e5, topicName=肺纤维化)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 06 11:40:11 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350631, encodeId=18aa350631b1, content=努力规范治疗,科学管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bj6C0FlaktgGwCTS7f0JsJHJrJZzjsIs01O5E893pPNfnxjbAtkhr5ocn6biau9PH1TE21jyr12GAA9zKBxUtpA/132, createdBy=c0d31628590, createdName=luolizhu, createdTime=Sat Oct 27 07:22:57 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291476, encodeId=b69b2914e6cc, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ec2274185, createdName=121afdd5m30暂无昵称, createdTime=Tue Feb 27 20:16:36 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291444, encodeId=0e51291444d1, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Feb 27 16:56:26 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=973307, encodeId=2aec9e330753, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 13 18:29:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82273, encryptionId=7d71822e3e5, topicName=肺纤维化)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 06 11:40:11 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350631, encodeId=18aa350631b1, content=努力规范治疗,科学管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bj6C0FlaktgGwCTS7f0JsJHJrJZzjsIs01O5E893pPNfnxjbAtkhr5ocn6biau9PH1TE21jyr12GAA9zKBxUtpA/132, createdBy=c0d31628590, createdName=luolizhu, createdTime=Sat Oct 27 07:22:57 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291476, encodeId=b69b2914e6cc, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ec2274185, createdName=121afdd5m30暂无昵称, createdTime=Tue Feb 27 20:16:36 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291444, encodeId=0e51291444d1, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Feb 27 16:56:26 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2018-10-27 luolizhu

    努力规范治疗,科学管理

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=973307, encodeId=2aec9e330753, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 13 18:29:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82273, encryptionId=7d71822e3e5, topicName=肺纤维化)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 06 11:40:11 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350631, encodeId=18aa350631b1, content=努力规范治疗,科学管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bj6C0FlaktgGwCTS7f0JsJHJrJZzjsIs01O5E893pPNfnxjbAtkhr5ocn6biau9PH1TE21jyr12GAA9zKBxUtpA/132, createdBy=c0d31628590, createdName=luolizhu, createdTime=Sat Oct 27 07:22:57 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291476, encodeId=b69b2914e6cc, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ec2274185, createdName=121afdd5m30暂无昵称, createdTime=Tue Feb 27 20:16:36 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291444, encodeId=0e51291444d1, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Feb 27 16:56:26 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2018-02-27 121afdd5m30暂无昵称

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=973307, encodeId=2aec9e330753, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 13 18:29:08 CST 2021, time=2021-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971274, encodeId=82279e1274ab, content=学习<a href='/topic/show?id=7d71822e3e5' target=_blank style='color:#2F92EE;'>#肺纤维化#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82273, encryptionId=7d71822e3e5, topicName=肺纤维化)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7ad5218670, createdName=14775a26m11暂无昵称, createdTime=Sun Jun 06 11:40:11 CST 2021, time=2021-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=350631, encodeId=18aa350631b1, content=努力规范治疗,科学管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/bj6C0FlaktgGwCTS7f0JsJHJrJZzjsIs01O5E893pPNfnxjbAtkhr5ocn6biau9PH1TE21jyr12GAA9zKBxUtpA/132, createdBy=c0d31628590, createdName=luolizhu, createdTime=Sat Oct 27 07:22:57 CST 2018, time=2018-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291476, encodeId=b69b2914e6cc, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49ec2274185, createdName=121afdd5m30暂无昵称, createdTime=Tue Feb 27 20:16:36 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291444, encodeId=0e51291444d1, content=^_^^_^^_^, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Swp2ehfHpiciczeTntUyQOlIGMzQ705ic67sdMTVMbwTv7KbmlUvxrGvRSvQZjPkz7ib5tEDfIaORgczPtmHDpwojg/0, createdBy=c54b2163125, createdName=wqkm, createdTime=Tue Feb 27 16:56:26 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2018-02-27 wqkm

    ^_^^_^^_^

    0